News Headlines

  1. CDMO Argonaut Manufacturing Services Partners With Particle Measuring Systems For Microbial And Particle Detection Solutions 2/25/2020

    Argonaut Manufacturing Services, a contract development and manufacturing organization (CDMO) for biopharmaceuticals, and Particle Measuring Systems (PMS), a contamination monitoring solutions company, have announced their ongoing partnership.

  2. Dipharma Francis S.r.l. Completes Construction Of New cGMP Suite In USA 2/24/2020

    Dipharma Francis S.r.l. (Dipharma), a leading Contract Development and Manufacturing Organization (CDMO) and a global manufacturer of Active Pharmaceutical Ingredients, announces today the completion of the new cGMP Quality Control laboratory and c-GMP kilolab at its CDMO site located in Kalamazoo (MI), USA. This press release features multimedia.

  3. Almac Clinical Services’ Just In Time Manufacturing Operations Pass EU Regulatory Inspection 2/18/2020

    Almac Clinical Services, a member of the global contract pharmaceutical development and manufacturing organisation, the Almac Group, today announced its Just in Time Manufacturing (JTM) processes have received GMP compliance certification from Ireland’s Health Products Regulatory Authority (HPRA). This assessment occurred as part of a recent inspection at the Group’s European campus in Dundalk, Ireland.

  4. Pelican BioThermal Opens Toronto Network Station 2/13/2020

    Pelican BioThermal, the global name in temperature- controlled packaging, announces the opening of a network station in Toronto to service its Crēdo on Demand rental program.

  5. PCI Pharma Services Announces Acquisition Of Bellwyck Pharma Services To Expand Global Clinical Trial Packaging Services 2/11/2020

    PCI Pharma Services (PCI), a leading pharmaceutical and biopharmaceutical global supply chain solutions provider, today announced the acquisition of Bellwyck Pharma Services (Bellwyck), headquartered in Toronto, Canada.

  6. Catalent And Zumutor Biologics Collaborate To Manufacture First-In-Class mAb To Treat Solid Tumors 2/11/2020

    Catalent, the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products, today announced that it has signed an agreement with Zumutor Biologics, Inc., to manufacture Zumutor’s lead candidate, ZM008, for the treatment of solid tumors.

  7. Catalent Completes Acquisition Of MaSTherCell 2/10/2020

    Catalent, Inc., the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products, today announced that it had completed its acquisition of MaSTherCell Global Inc., positioning Catalent as a premier technology, development and manufacturing partner for innovators of advanced biotherapeutics.

  8. Novo Nordisk Invests DKK 800 Million In Upgrading And Expanding Production Facilities In Kalundborg 2/7/2020

    Novo Nordisk today announced plans to invest DKK 800 million in upgrading and expanding facilities at its production site in Kalundborg, Denmark.

  9. AstraZeneca To Plant 25 Million Trees In Australia And Invest $200M In Local Manufacturing 2/7/2020

    AstraZeneca’s Chief Executive Officer, Pascal Soriot and its Chairman, Leif Johansson, were today joined by Britain’s Foreign Secretary, Dominic Raab and Australia’s Federal Minister for the Environment, Sussan Ley, to plant the first of 25 million trees in Australia as part of the Company’s global commitment to plant 50 million trees worldwide over the next five years.

  10. LSNE Expands Vial Filling And Lyophilization Capacity With Isolator Technology 2/5/2020

    LSNE Contract Manufacturing, a leading contract development and manufacturing organization, broke ground on a 26,000 square foot addition of its existing 7 Commerce facility on the Bedford, New Hampshire campus.